Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Mise à jour : Il y a 4 ans
Référence : NCT02534909

Femme et Homme

Extrait

To determine whether LFG316 can induce a hematological response, as measured by reduction in hemolytic activity, in patients with PNH.


Critère d'inclusion

  • Paroxysmal nocturnal hemoglobinuria (PNH)

Liens